Page QSant - Section 1 BIS - The Problem

Early and accurate identification of rejection risk is critical for proactive management of transplant health.
Non-invasive screening should pave the way for earlier detection and intervention, however most available non-invasive tests fall short.

Page QSant - Section 4 - col 2 Remote sampling

Comprehensive results

DNA

  • A personalized risk that that goes beyond a simple signal of rejection.
  • QSant™ detects a variety of rejection types and can be used on pediatric patients, multi-organ transplant recipients, pregnant patients, sibling and identical twin-donors, and repeat transplant patients.
Generate Q-Score
Monitor Q-Score
High Risk Q-Score